|
| 36127525 | Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database. | Arch Gynecol Obstet | 2023 |
| 35835922 | Atypical course of a caesarean scar pregnancy. | Arch Gynecol Obstet | 2023 |
| 35939115 | Improved preoperative risk stratification in endometrial carcinoma patients: external validation of the ENDORISK Bayesian network model in a large population-based case series. | J Cancer Res Clin Oncol | 2023 |
| 36127525 | Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database. | Arch Gynecol Obstet | 2023 |
| 36427596 | Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study. | Am J Obstet Gynecol | 2023 |
| 37588260 | Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures. | Geburtshilfe Frauenheilkd | 2023 |
| 36973448 | Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse. | Br J Cancer | 2023 |
| 37339172 | The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. | Clin Cancer Res | 2023 |
| 36707423 | A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany. | Arch Gynecol Obstet | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 36753816 | Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. | Gynecol Oncol | 2023 |
| 36631151 | Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1). | Int J Gynecol Cancer | 2023 |
| 37240703 | Improvement in Fertility and Pain after Endometriosis Resection and Adhesion Prevention with 4DryField<sup>®</sup> PH: Follow-up of a Randomized Controlled Clinical Trial. | J Clin Med | 2023 |
| 37182372 | Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]. | Mod Pathol | 2023 |
| 37168255 | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers. | Front Mol Biosci | 2023 |
| 36731023 | Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol. | Int J Gynecol Pathol | 2023 |
| 37425832 | Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction. | bioRxiv | 2023 |
| 36852510 | L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression. | Am J Surg Pathol | 2023 |
| 36788084 | Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death. | Mod Pathol | 2023 |
| 36975108 | Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database. | J Surg Oncol | 2023 |
| 37588260 | Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures. | Geburtshilfe Frauenheilkd | 2023 |
| 35835922 | Atypical course of a caesarean scar pregnancy. | Arch Gynecol Obstet | 2023 |
| 37425832 | Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction. | bioRxiv | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37182372 | Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]. | Mod Pathol | 2023 |
| 37240703 | Improvement in Fertility and Pain after Endometriosis Resection and Adhesion Prevention with 4DryField<sup>®</sup> PH: Follow-up of a Randomized Controlled Clinical Trial. | J Clin Med | 2023 |
| 36975108 | Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database. | J Surg Oncol | 2023 |
| 37339172 | The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. | Clin Cancer Res | 2023 |
| 36973448 | Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse. | Br J Cancer | 2023 |
| 37168255 | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers. | Front Mol Biosci | 2023 |
| 36753816 | Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. | Gynecol Oncol | 2023 |
| 36788084 | Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death. | Mod Pathol | 2023 |
| 36852510 | L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression. | Am J Surg Pathol | 2023 |
| 36427596 | Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study. | Am J Obstet Gynecol | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36707423 | A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany. | Arch Gynecol Obstet | 2023 |
| 36731023 | Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol. | Int J Gynecol Pathol | 2023 |
| 36631151 | Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1). | Int J Gynecol Cancer | 2023 |
| 35939115 | Improved preoperative risk stratification in endometrial carcinoma patients: external validation of the ENDORISK Bayesian network model in a large population-based case series. | J Cancer Res Clin Oncol | 2023 |
| 34845668 | Large Conization-Retrospective Monocentric Results for Fertility Preservation in Young Women with Early Stage Cervical Cancer. | Reprod Sci | 2022 |
| 35715244 | Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes. | Fertil Steril | 2022 |
| 35443283 | Electrosurgery and Other Technical Advancements in Minimally Invasive Gynecological Surgery - An Update. | Surg Technol Int | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 36078873 | Multiparametric Dual-Time-Point [<sup>18</sup>F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma. | J Clin Med | 2022 |
| 36001383 | Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant. | Clin Cancer Res | 2022 |
| 36191839 | Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling. | J Mol Diagn | 2022 |
| 36503580 | Acidic ascites inhibits ovarian cancer cell proliferation and correlates with the metabolomic, lipidomic and inflammatory phenotype of human patients. | J Transl Med | 2022 |
| 34782936 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. | Virchows Arch | 2022 |
| 34963005 | Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. | J Natl Cancer Inst | 2022 |